Developing vaccines to augment the anti-tumor effect of immune checkpoint blockade

被引：0
|
作者：
Eiro, Melisa Daiana Castro [1 ]
Wilmsen, Merel [1 ]
Brouwers-haspels, Inge [1 ]
Kiernan, Caoimhe H. Van der Wel [1 ]
Zhao, Manzhi [1 ]
Li, Ling [1 ]
Van Meurs, Marjan [1 ]
Mueller, Yvonne M. [1 ]
Schliehe, Christopher [1 ]
Ishii, Ken [2 ]
Van Eijck, Casper [3 ]
Katsikis, Peter D. [1 ]
机构：
[1] Erasmus MC, Dept Immunol, Rotterdam, Netherlands
[2] Minist Hlth Labour & Welf MHLW, Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Ctr Vaccine & Adjuvant Res CVAR, Tokyo, Japan
[3] Erasmus MC, Dept Surg, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Adjuvants and vaccines; anti-cancer vaccine; cancer immunology; checkpoint inhibition;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-1010
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [41] IL-9 stimulates an anti-tumor immune response and facilitates immune checkpoint blockade in the CMT167 mouse model
    Feng, Yuqian
    Yan, Sheng
    Lam, Sze Kwan
    Ko, Frankie Chi Fat
    Chen, Caoyang
    Khan, Mahjabin
    Ho, James Chung-Man
    LUNG CANCER, 2022, 174 : 14 - 26
  • [42] Effects of antibiotics on the anti-tumor efficacy of immune checkpoint inhibitor therapy
    Nie, Fangfang
    Guo, Jungang
    Pan, Jiayi
    Guo, Zhaojiao
    Wang, Chun
    Yan, Jun
    Ma, Weina
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, : 790 - 799
  • [43] Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade
    Rwandamuriye, Francois Xavier
    Wang, Tao
    Zhang, Hanfu
    Elaskalani, Omar
    Kuster, Jorren
    Ye, Xueting
    Vitali, Breana
    Schreurs, Juliet
    Morales, M. Lizeth Orozco
    Norret, Marck
    Evans, Cameron W.
    Zemek, Rachael M.
    Iyer, K. Swaminathan
    Lesterhuis, W. Joost
    Wylie, Ben
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [44] Multi-Omics Analysis of the Anti-tumor Synergistic Mechanism and Potential Application of Immune Checkpoint Blockade Combined With Lenvatinib
    Lu, Yuting
    Jin, Jiangtao
    Du, Qi
    Hu, Min
    Wei, Yuhan
    Wang, Miao
    Li, Hongzhong
    Li, Qin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [45] Enhancing Anti-Tumor Immunity and Responses to Immune Checkpoint Blockade By Suppressing Interleukin-10 in Chronic Lymphocytic Leukemia
    Rivas, Jacqueline R.
    Alhakeem, Sara S.
    Eckenrode, Joseph M.
    Zhang, Yinan
    Collard, James P.
    Hildebrandt, Gerhard C.
    Fleischman, Roger A.
    Chen, Li
    Thorson, Jon S.
    Leggas, Markos
    Bondada, Subbarao
    BLOOD, 2019, 134
  • [46] Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
    Das, Satya
    Johnson, Douglas B.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [47] Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response
    Coschi, Courtney H.
    Juergens, Rosalyn A.
    CURRENT ONCOLOGY, 2024, 31 (01) : 1 - 23
  • [48] Perspective: cancer vaccines in the era of immune checkpoint blockade
    Cebon, Jonathan
    MAMMALIAN GENOME, 2018, 29 (11-12) : 703 - 713
  • [49] Perspective: cancer vaccines in the era of immune checkpoint blockade
    Jonathan Cebon
    Mammalian Genome, 2018, 29 : 703 - 713
  • [50] A novel polyamine blockade therapy activates an anti-tumor immune response
    Alexander, Eric T.
    Minton, Allyson
    Peters, Molly C.
    Phanstiel, Otto
    Gilmour, Susan K.
    ONCOTARGET, 2017, 8 (48) : 84140 - 84152
12345